Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Empagliflozin Use Is Associated With Lower Risk of All‐Cause Mortality, Hospitalization for Heart Failure, and End‐Stage Renal Disease Compared to DPP‐4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study

Autor: Langslet, Gisle¹ (AUTHOR), Nyström, Thomas² (AUTHOR), Vistisen, Dorte^3,4 (AUTHOR), Carstensen, Bendix³ (AUTHOR), Grip, Emilie Toresson^5,6 (AUTHOR), Casajust, Paula⁷ (AUTHOR), Tskhvarashvili, Giorgi⁸ (AUTHOR), Hoti, Fabian⁹ (AUTHOR), Klement, Riho¹⁰ (AUTHOR), Karlsdotter, Kristina¹¹ (AUTHOR), Tuovinen, Mikko¹² (AUTHOR), Ofstad, Anne Pernille^13,14 (AUTHOR), Lajer, Maria¹⁵ (AUTHOR), Shay, Christina¹⁶ (AUTHOR) christina.shay@boehringer-ingelheim.com, Koeneman, Lisette¹⁷ (AUTHOR), Farsani, Soulmaz Fazeli¹⁸ (AUTHOR), Niskanen, Leo^19,20 (AUTHOR), Halvorsen, Sigrun^21,22 (AUTHOR), Infante, Marco (AUTHOR) marco.infante@unicamillus.org

Publikováno v: Journal of Diabetes Research. 10/12/2024, Vol. 2024, p1-22. 22p.

Diabetes and cardiovascular disease in older adults.

Autor: Bilal A; AdventHealth Translational Research Institute, Orlando, Florida, USA., Pratley R; AdventHealth Translational Research Institute, Orlando, Florida, USA.; AdventHealth Diabetes Institute, Orlando, Florida, USA.

Publikováno v: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2024 Dec 12. Date of Electronic Publication: 2024 Dec 12.

急性冠脉综合征不良心血管事件机器学习预测 模型的研究进展.

Autor: 周仟慧¹, 古满平¹ 366964157@qq.com

Publikováno v: Journal of Modern Medicine & Health. 9/15/2024, Vol. 40 Issue 17, p3023-3027. 5p.

5 个原研二肽基肽酶 4 抑制剂的综合评价.

Autor: 李力任¹ 349714948@qq.com, 阮 洁², 朱柏霖³, 张 琳⁴, 钟询龙⁵, 何关生⁵, 李晓曦⁶, 朱晓冉⁷, 刘 腾⁸, 王若伦⁵, 林 阳⁴, 金鹏 飞³, 王建华², 郑 萍¹, 刘世霆¹, 董占军⁷, 李亦蕾¹ 1592286187@qq.com, 赵志刚⁸ 1022zzg@sina.com

Publikováno v: Evaluation & Analysis of Drug-Use in Hospitals of China. 2024, Vol. 24 Issue 8, p989-994. 6p.